Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stefano Scabini
Elevated Platelet Count Is a Negative Predictive and Prognostic Marker in Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiation: A Retrospective Multi-Institutional Study on 965 Patients
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Formation of Polyploid Giant Cancer Cells Involves in the Prognostic Value of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
Journal of Oncology
Oncology
Effect of Adding mFOLFOX6 After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Multicentre, Phase 2 Trial
The Lancet Oncology
Oncology
Capecitabine and Oxaliplatin Versus 5-Fluorouracil in the Neoadjuvant Chemoradiation for Patients With Locally Advanced Rectal Carcinoma: A Comparative Study
Journal of Cancer Therapy
Phase 1b/2 Study of Neoadjuvant Chemoradiation Therapy With CRLX101 and Capecitabine for Locally Advanced Rectal Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Can Diffusion-Weighted MRI Determine Complete Responders After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer?
Diagnostic and Interventional Radiology
Nuclear Medicine
Radiology
Cardiovascular Medicine
Imaging
Cardiology
Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer
Clinical Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Skeletal Muscle Loss Is an Independent Negative Prognostic Factor in Patients With Advanced Lower Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy
PLoS ONE
Multidisciplinary
Recent Advances in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Journal of the Anus, Rectum and Colon
A Novel LARCassigner3 Classification Predicts Outcomes in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: A Retrospective Training and Validation Analysis
Cancer Management and Research
Oncology
